These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 18771349)
21. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672 [TBL] [Abstract][Full Text] [Related]
22. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival. Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020 [TBL] [Abstract][Full Text] [Related]
23. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in 1,521 melanoma patients with distant metastases. Barth A; Wanek LA; Morton DL J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677 [TBL] [Abstract][Full Text] [Related]
25. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
26. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409 [TBL] [Abstract][Full Text] [Related]
27. Malignant melanoma: relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II. Lee JE; Lu M; Mansfield PF; Platsoucas CD; Reveille JD; Ross MI Cancer; 1996 Aug; 78(4):758-63. PubMed ID: 8756369 [TBL] [Abstract][Full Text] [Related]
28. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715 [TBL] [Abstract][Full Text] [Related]
29. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study. Crocetti E; Mangone L; Lo Scocco G; Carli P Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092 [TBL] [Abstract][Full Text] [Related]
30. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA. Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma. Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991 [TBL] [Abstract][Full Text] [Related]
32. Blood mRNA expression profiling predicts survival in patients treated with tremelimumab. Saenger Y; Magidson J; Liaw B; de Moll E; Harcharik S; Fu Y; Wassmann K; Fisher D; Kirkwood J; Oh WK; Friedlander P Clin Cancer Res; 2014 Jun; 20(12):3310-8. PubMed ID: 24721645 [TBL] [Abstract][Full Text] [Related]
33. Role of promyelocytic leukemia zinc finger protein in proliferation of cultured human corneal endothelial cells. Shiraishi A; Joko T; Higashiyama S; Ohashi Y Cornea; 2007 Oct; 26(9 Suppl 1):S55-8. PubMed ID: 17881917 [TBL] [Abstract][Full Text] [Related]
34. Melastatin expression and prognosis in cutaneous malignant melanoma. Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852 [TBL] [Abstract][Full Text] [Related]
35. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179 [TBL] [Abstract][Full Text] [Related]
36. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma. Glumac N; Snoj M; Hocevar M; Novakovic S Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006 [TBL] [Abstract][Full Text] [Related]